www.fdanews.com/articles/132361-fda-advisory-panel-endorses-approval-of-solesta
FDA Advisory Panel Endorses Approval of Solesta
December 3, 2010
An FDA Advisory Panel voted 5–0, with one abstention, that the benefits of Solesta outweigh its risks.
iStockAnalyst
iStockAnalyst